4//SEC Filing
Esperion Therapeutics, Inc. 4
Accession 0001179110-15-005315
$ESPRCIK 0001434868operating
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:16 PM ET
Size
5.4 KB
Accession
0001179110-15-005315
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock option (right to buy)
2015-03-18+20,000→ 20,000 totalExercise: $105.72Exp: 2025-03-18→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]25% of option vests on March 18, 2016 and the remainder shall vest in equal quarterly installments over a three (3) year period thereafter.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001434868
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 6:16 PM ET
- Size
- 5.4 KB